Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

7431402

Reference Type

Journal Article

Title

Prospective study of human herpesvirus type 8 serostatus and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial

Author(s)

Sutcliffe, S; Till, C; Jenkins, FJ; Gaydos, CA; Goodman, PJ; Hoque, AM; Hsing, AnnW; Thompson, IanM; Nelson, WG; De Marzo, AM; Platz, EA; ,

Year

2014

Is Peer Reviewed?

Yes

Journal

Cancer Causes and Control
ISSN: 0957-5243
EISSN: 1573-7225

Page Numbers

35-44

DOI

10.1007/s10552-014-0480-5

URL

http://link.springer.com/10.1007/s10552-014-0480-5
Exit

Abstract

Human herpesvirus type 8 (HHV-8), a gamma herpesvirus associated with Kaposi’s sarcoma, has been proposed as a candidate risk factor for prostate cancer (PCa) because of its detection in benign and malignant prostate specimens, and its relation with histologic prostatic inflammation. We investigated the possible relation between pre-diagnostic HHV-8 infection and PCa risk in a case–control study sampled from the placebo arm of the Prostate Cancer Prevention Trial.